vs
Side-by-side financial comparison of LIFECORE BIOMEDICAL, INC. \DE\ (LFCR) and Plymouth Industrial REIT, Inc. (PLYM). Click either name above to swap in a different company.
Plymouth Industrial REIT, Inc. is the larger business by last-quarter revenue ($51.2M vs $31.1M, roughly 1.6× LIFECORE BIOMEDICAL, INC. \DE\). LIFECORE BIOMEDICAL, INC. \DE\ runs the higher net margin — -32.1% vs -106.3%, a 74.1% gap on every dollar of revenue. On growth, Plymouth Industrial REIT, Inc. posted the faster year-over-year revenue change (-1.4% vs -4.5%). Over the past eight quarters, Plymouth Industrial REIT, Inc.'s revenue compounded faster (0.4% CAGR vs -0.1%).
LIFECORE BIOMEDICAL, INC. is a biomedical firm focused on developing and manufacturing high-quality hyaluronic acid-based biomaterials. It operates three core segments: medical application products, pharmaceutical solutions, and personal care ingredients, with main markets spanning North America, Europe and the Asia-Pacific, supplying to leading medical device, pharmaceutical and cosmetic brand partners.
Plymouth Industrial REIT, Inc. is a real estate investment trust focused on owning, operating, and acquiring high-quality industrial properties including distribution centers, warehouses, and light industrial facilities across key U.S. logistics hubs. It serves tenants in e-commerce, retail, manufacturing, and third-party logistics sectors, supporting diverse business supply chain needs.
LFCR vs PLYM — Head-to-Head
Income Statement — Q2 FY2026 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $31.1M | $51.2M |
| Net Profit | $-10.0M | $-54.4M |
| Gross Margin | 25.0% | — |
| Operating Margin | -9.9% | -102.5% |
| Net Margin | -32.1% | -106.3% |
| Revenue YoY | -4.5% | -1.4% |
| Net Profit YoY | -52.0% | -248.5% |
| EPS (diluted) | $-0.29 | $-1.23 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q3 25 | $31.1M | $51.2M | ||
| Q2 25 | — | $47.2M | ||
| Q1 25 | $35.2M | $45.6M | ||
| Q4 24 | $32.6M | $47.6M | ||
| Q3 24 | $24.7M | $51.9M | ||
| Q2 24 | — | $48.7M | ||
| Q1 24 | $35.7M | $50.2M | ||
| Q4 23 | $30.1M | $50.8M |
| Q3 25 | $-10.0M | $-54.4M | ||
| Q2 25 | — | $-6.1M | ||
| Q1 25 | $-14.8M | $5.8M | ||
| Q4 24 | $-6.6M | $147.4M | ||
| Q3 24 | $-16.2M | $-15.6M | ||
| Q2 24 | — | $1.3M | ||
| Q1 24 | $15.6M | $6.2M | ||
| Q4 23 | $14.2M | $9.3M |
| Q3 25 | 25.0% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 28.0% | — | ||
| Q4 24 | 34.0% | — | ||
| Q3 24 | 21.8% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 33.3% | — | ||
| Q4 23 | 33.0% | — |
| Q3 25 | -9.9% | -102.5% | ||
| Q2 25 | — | -10.3% | ||
| Q1 25 | -25.7% | — | ||
| Q4 24 | -6.0% | — | ||
| Q3 24 | -46.9% | -29.6% | ||
| Q2 24 | — | 2.7% | ||
| Q1 24 | -2.5% | — | ||
| Q4 23 | -4.9% | — |
| Q3 25 | -32.1% | -106.3% | ||
| Q2 25 | — | -12.9% | ||
| Q1 25 | -42.0% | 12.8% | ||
| Q4 24 | -20.2% | 309.9% | ||
| Q3 24 | -65.7% | -30.1% | ||
| Q2 24 | — | 2.7% | ||
| Q1 24 | 43.8% | 12.4% | ||
| Q4 23 | 47.2% | 18.3% |
| Q3 25 | $-0.29 | $-1.23 | ||
| Q2 25 | — | $-0.14 | ||
| Q1 25 | $-0.47 | $0.13 | ||
| Q4 24 | $-0.25 | $3.24 | ||
| Q3 24 | $-0.53 | $-0.35 | ||
| Q2 24 | — | $0.03 | ||
| Q1 24 | $0.42 | $0.14 | ||
| Q4 23 | $0.39 | $0.21 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $18.9M | — |
| Total DebtLower is stronger | $136.0M | — |
| Stockholders' EquityBook value | $-10.5M | $470.1M |
| Total Assets | $235.2M | $1.6B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | $18.9M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $5.4M | — | ||
| Q4 24 | $9.5M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — |
| Q3 25 | $136.0M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $124.9M | — | ||
| Q4 24 | $111.3M | $646.4M | ||
| Q3 24 | $106.3M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $97.1M | — | ||
| Q4 23 | $92.9M | $873.4M |
| Q3 25 | $-10.5M | $470.1M | ||
| Q2 25 | — | $539.6M | ||
| Q1 25 | $2.2M | $571.0M | ||
| Q4 24 | $15.4M | $579.5M | ||
| Q3 24 | $-3.9M | $436.5M | ||
| Q2 24 | — | $475.2M | ||
| Q1 24 | $17.7M | $484.6M | ||
| Q4 23 | $1.4M | $483.0M |
| Q3 25 | $235.2M | $1.6B | ||
| Q2 25 | — | $1.6B | ||
| Q1 25 | $237.7M | $1.4B | ||
| Q4 24 | $255.4M | $1.4B | ||
| Q3 24 | $246.8M | $1.5B | ||
| Q2 24 | — | $1.4B | ||
| Q1 24 | $246.2M | $1.4B | ||
| Q4 23 | $245.8M | $1.4B |
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 56.05× | — | ||
| Q4 24 | 7.20× | 1.12× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 5.49× | — | ||
| Q4 23 | 65.35× | 1.81× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $1.8M | $20.0M |
| Free Cash FlowOCF − Capex | $25.0K | — |
| FCF MarginFCF / Revenue | 0.1% | — |
| Capex IntensityCapex / Revenue | 5.6% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-16.8M | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | $1.8M | $20.0M | ||
| Q2 25 | — | $23.4M | ||
| Q1 25 | $1.2M | $15.6M | ||
| Q4 24 | $-6.1M | $96.1M | ||
| Q3 24 | $-613.0K | $17.6M | ||
| Q2 24 | — | $19.9M | ||
| Q1 24 | $-1.4M | $16.6M | ||
| Q4 23 | $1.3M | $18.6M |
| Q3 25 | $25.0K | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $-4.3M | — | ||
| Q4 24 | $-8.6M | — | ||
| Q3 24 | $-4.0M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $-7.8M | — | ||
| Q4 23 | $-3.0M | — |
| Q3 25 | 0.1% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | -12.1% | — | ||
| Q4 24 | -26.3% | — | ||
| Q3 24 | -16.3% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -21.8% | — | ||
| Q4 23 | -9.9% | — |
| Q3 25 | 5.6% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 15.5% | — | ||
| Q4 24 | 7.5% | — | ||
| Q3 24 | 13.9% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 17.8% | — | ||
| Q4 23 | 14.1% | — |
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 2.67× | ||
| Q4 24 | — | 0.65× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 15.12× | ||
| Q1 24 | -0.09× | 2.67× | ||
| Q4 23 | 0.09× | 2.01× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
LFCR
| Transferred At Point In Time | $26.6M | 85% |
| Transferred Over Time | $4.5M | 15% |
PLYM
Segment breakdown not available.
